FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079553387> ?p ?o ?g. }

• W2079553387 endingPage "223" @default.
• W2079553387 startingPage "214" @default.
• W2079553387 abstract "Background Hepatic ischemia-reperfusion (HIR) is a severe condition that is seen after hepatic arterial injury and in hepatic grafts in living donor transplantation. HIR not only causes liver injury by lipid peroxidation, but also stimulates systemic and portal endotoxemia. Also, lipopolysaccharide (LPS) induces hepatic injury mediated by inducible nitric oxide synthase (iNOS). There is little knowledge on the role of specific iNOS inhibitors in prevention of HIR injury followed by LPS administration. The aim of this study on a LPS induced HIR model was to investigate the effect of aminoguanidine (AG) administration on hepatic tissue iNOS expression and lipid peroxidation when given before or after LPS. Methods Six groups were designed; A: Sham, B: HIR, C: HIR + AG, D: HIR + LPS, E: HIR + LPS + AG, F: HIR + AG + LPS. No substance was given to the rats in Group A and B. HIR injury was induced with vascular occlusion for 45 min and reperfusion for 45 min. Drugs were given intraperitoneally 10 min before reperfusion. Serum and tissue analysis for myeloperoxidase (MPO), and malondialdehyde (MDA), and tissue NA+/K+ adenosine 5′triphosphatases (ATPase) and tissue iNOS staining were performed. Permission for this study was obtained from the local Ethics Committee. Results The level of MPO, MDA, and iNOS staining scores in Group B were significantly higher than Group A and ATPase was lower in Group B (P < 0.05). Contrary to results in Group C, results of MPO, MDA, and iNOS staining scores of Group D was higher than Group B (P < 0.05); however, although iNOS in Group C was lower than Group B, the difference was not significant (P > 0.05). MPO and MDA levels of Groups E and F were significantly lower than Group D. Level of ATPase in Group F was significantly different from Groups D and E. iNOS scoring was low in Group F compared with Group D (P < 0.05). MDA, MPO, and iNOS levels of Group F was lower than Group E, and ATPase of Group F was higher than Group E (P < 0.05). Conclusions The results of this study in a LPS induced HIR model showed that LPS after HIR aggravated HIR injury by increasing neutrophil activation and lipid peroxidation both in serum and liver tissue and iNOS in liver, and depleting energy in liver. AG, a selective iNOS inhibitor, ameliorated the negative effects of endotoxemia induced by LPS after HIR; however, energy depletion and iNOS expression in liver tissue were attenuated only when AG was administered prior to LPS. The findings of this study supported the hypothesis that LPS after HIR would aggravate HIR injury and AG would ameliorate this aggravated injury. Hepatic ischemia-reperfusion (HIR) is a severe condition that is seen after hepatic arterial injury and in hepatic grafts in living donor transplantation. HIR not only causes liver injury by lipid peroxidation, but also stimulates systemic and portal endotoxemia. Also, lipopolysaccharide (LPS) induces hepatic injury mediated by inducible nitric oxide synthase (iNOS). There is little knowledge on the role of specific iNOS inhibitors in prevention of HIR injury followed by LPS administration. The aim of this study on a LPS induced HIR model was to investigate the effect of aminoguanidine (AG) administration on hepatic tissue iNOS expression and lipid peroxidation when given before or after LPS. Six groups were designed; A: Sham, B: HIR, C: HIR + AG, D: HIR + LPS, E: HIR + LPS + AG, F: HIR + AG + LPS. No substance was given to the rats in Group A and B. HIR injury was induced with vascular occlusion for 45 min and reperfusion for 45 min. Drugs were given intraperitoneally 10 min before reperfusion. Serum and tissue analysis for myeloperoxidase (MPO), and malondialdehyde (MDA), and tissue NA+/K+ adenosine 5′triphosphatases (ATPase) and tissue iNOS staining were performed. Permission for this study was obtained from the local Ethics Committee. The level of MPO, MDA, and iNOS staining scores in Group B were significantly higher than Group A and ATPase was lower in Group B (P < 0.05). Contrary to results in Group C, results of MPO, MDA, and iNOS staining scores of Group D was higher than Group B (P < 0.05); however, although iNOS in Group C was lower than Group B, the difference was not significant (P > 0.05). MPO and MDA levels of Groups E and F were significantly lower than Group D. Level of ATPase in Group F was significantly different from Groups D and E. iNOS scoring was low in Group F compared with Group D (P < 0.05). MDA, MPO, and iNOS levels of Group F was lower than Group E, and ATPase of Group F was higher than Group E (P < 0.05). The results of this study in a LPS induced HIR model showed that LPS after HIR aggravated HIR injury by increasing neutrophil activation and lipid peroxidation both in serum and liver tissue and iNOS in liver, and depleting energy in liver. AG, a selective iNOS inhibitor, ameliorated the negative effects of endotoxemia induced by LPS after HIR; however, energy depletion and iNOS expression in liver tissue were attenuated only when AG was administered prior to LPS. The findings of this study supported the hypothesis that LPS after HIR would aggravate HIR injury and AG would ameliorate this aggravated injury." @default.
• W2079553387 created "2016-06-24" @default.
• W2079553387 creator A5007844480 @default.
• W2079553387 creator A5019673982 @default.
• W2079553387 creator A5031081664 @default.
• W2079553387 creator A5031649334 @default.
• W2079553387 creator A5041951997 @default.
• W2079553387 creator A5044698904 @default.
• W2079553387 creator A5048539684 @default.
• W2079553387 creator A5055228362 @default.
• W2079553387 creator A5078384848 @default.
• W2079553387 date "2008-08-01" @default.
• W2079553387 modified "2023-09-26" @default.
• W2079553387 title "Liver Tissue Inducible Nitric Oxide Synthase (iNOS) Expression and Lipid Peroxidation in Experimental Hepatic Ischemia Reperfusion Injury Stimulated With Lipopolysaccharide: The Role of Aminoguanidine" @default.
• W2079553387 cites W111374461 @default.
• W2079553387 cites W144506950 @default.
• W2079553387 cites W1574945736 @default.
• W2079553387 cites W1775749144 @default.
• W2079553387 cites W1969161905 @default.
• W2079553387 cites W1970890994 @default.
• W2079553387 cites W1975006563 @default.
• W2079553387 cites W1976411466 @default.
• W2079553387 cites W1976831711 @default.
• W2079553387 cites W1991615383 @default.
• W2079553387 cites W2006061373 @default.
• W2079553387 cites W2010961118 @default.
• W2079553387 cites W2018210625 @default.
• W2079553387 cites W2027303041 @default.
• W2079553387 cites W2030894742 @default.
• W2079553387 cites W2034003769 @default.
• W2079553387 cites W2037597903 @default.
• W2079553387 cites W2041024569 @default.
• W2079553387 cites W2041334088 @default.
• W2079553387 cites W2042569561 @default.
• W2079553387 cites W2042961275 @default.
• W2079553387 cites W2049698997 @default.
• W2079553387 cites W2051752915 @default.
• W2079553387 cites W2055702194 @default.
• W2079553387 cites W2073192795 @default.
• W2079553387 cites W2080221579 @default.
• W2079553387 cites W2081828836 @default.
• W2079553387 cites W2090273924 @default.
• W2079553387 cites W2090843821 @default.
• W2079553387 cites W2108031740 @default.
• W2079553387 cites W211866190 @default.
• W2079553387 cites W2127590077 @default.
• W2079553387 cites W2150195134 @default.
• W2079553387 cites W2153232639 @default.
• W2079553387 cites W4249223069 @default.
• W2079553387 doi "https://doi.org/10.1016/j.jss.2007.10.008" @default.
• W2079553387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18222473" @default.
• W2079553387 hasPublicationYear "2008" @default.
• W2079553387 type Work @default.
• W2079553387 sameAs 2079553387 @default.
• W2079553387 citedByCount "25" @default.
• W2079553387 countsByYear W20795533872012 @default.
• W2079553387 countsByYear W20795533872013 @default.
• W2079553387 countsByYear W20795533872014 @default.
• W2079553387 countsByYear W20795533872015 @default.
• W2079553387 countsByYear W20795533872016 @default.
• W2079553387 countsByYear W20795533872017 @default.
• W2079553387 countsByYear W20795533872018 @default.
• W2079553387 countsByYear W20795533872019 @default.
• W2079553387 countsByYear W20795533872022 @default.
• W2079553387 crossrefType "journal-article" @default.
• W2079553387 hasAuthorship W2079553387A5007844480 @default.
• W2079553387 hasAuthorship W2079553387A5019673982 @default.
• W2079553387 hasAuthorship W2079553387A5031081664 @default.
• W2079553387 hasAuthorship W2079553387A5031649334 @default.
• W2079553387 hasAuthorship W2079553387A5041951997 @default.
• W2079553387 hasAuthorship W2079553387A5044698904 @default.
• W2079553387 hasAuthorship W2079553387A5048539684 @default.
• W2079553387 hasAuthorship W2079553387A5055228362 @default.
• W2079553387 hasAuthorship W2079553387A5078384848 @default.
• W2079553387 hasConcept C126322002 @default.
• W2079553387 hasConcept C134018914 @default.
• W2079553387 hasConcept C185592680 @default.
• W2079553387 hasConcept C203565725 @default.
• W2079553387 hasConcept C2776151105 @default.
• W2079553387 hasConcept C2776637226 @default.
• W2079553387 hasConcept C2776914184 @default.
• W2079553387 hasConcept C2777622882 @default.
• W2079553387 hasConcept C2778401633 @default.
• W2079553387 hasConcept C2778754761 @default.
• W2079553387 hasConcept C2780114680 @default.
• W2079553387 hasConcept C2780829032 @default.
• W2079553387 hasConcept C519581460 @default.
• W2079553387 hasConcept C541997718 @default.
• W2079553387 hasConcept C71924100 @default.
• W2079553387 hasConcept C98274493 @default.
• W2079553387 hasConceptScore W2079553387C126322002 @default.
• W2079553387 hasConceptScore W2079553387C134018914 @default.
• W2079553387 hasConceptScore W2079553387C185592680 @default.
• W2079553387 hasConceptScore W2079553387C203565725 @default.
• W2079553387 hasConceptScore W2079553387C2776151105 @default.
• W2079553387 hasConceptScore W2079553387C2776637226 @default.
• W2079553387 hasConceptScore W2079553387C2776914184 @default.
• W2079553387 hasConceptScore W2079553387C2777622882 @default.

• next